Mark Sheptoff Financial Planning LLC Acquires 1,677 Shares of CVS Health Co. (NYSE:CVS)

Mark Sheptoff Financial Planning LLC boosted its holdings in shares of CVS Health Co. (NYSE:CVS) by 46.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,249 shares of the pharmacy operator’s stock after acquiring an additional 1,677 shares during the quarter. Mark Sheptoff Financial Planning LLC’s holdings in CVS Health were worth $310,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Wedmont Private Capital boosted its holdings in CVS Health by 0.8% in the 1st quarter. Wedmont Private Capital now owns 19,225 shares of the pharmacy operator’s stock valued at $1,410,000 after purchasing an additional 146 shares during the period. Moody National Bank Trust Division boosted its stake in CVS Health by 0.7% during the first quarter. Moody National Bank Trust Division now owns 22,268 shares of the pharmacy operator’s stock valued at $1,776,000 after buying an additional 150 shares during the period. Landmark Financial Advisors LLC grew its position in CVS Health by 3.8% during the fourth quarter. Landmark Financial Advisors LLC now owns 4,166 shares of the pharmacy operator’s stock worth $329,000 after buying an additional 153 shares in the last quarter. Garland Capital Management Inc. grew its holdings in shares of CVS Health by 0.3% during the second quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator’s stock worth $3,591,000 after purchasing an additional 160 shares in the last quarter. Finally, Sepio Capital LP grew its stake in CVS Health by 1.7% in the 4th quarter. Sepio Capital LP now owns 9,907 shares of the pharmacy operator’s stock worth $782,000 after buying an additional 163 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Trading Up 1.0 %

NYSE:CVS opened at $58.42 on Thursday. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. The company has a 50-day moving average price of $58.33 and a 200-day moving average price of $62.74. The stock has a market cap of $73.34 billion, a price-to-earnings ratio of 10.27, a P/E/G ratio of 0.79 and a beta of 0.53.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business had revenue of $91.23 billion for the quarter, compared to analysts’ expectations of $91.41 billion. During the same period in the previous year, the firm posted $2.21 EPS. The business’s revenue was up 2.6% on a year-over-year basis. Equities analysts predict that CVS Health Co. will post 6.51 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 1st. Shareholders of record on Monday, July 22nd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.55%. The ex-dividend date was Monday, July 22nd. CVS Health’s dividend payout ratio is currently 46.75%.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of research analyst reports. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a report on Monday. Royal Bank of Canada reiterated an “outperform” rating and set a $68.00 price objective on shares of CVS Health in a research report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft dropped their target price on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Wells Fargo & Company lifted their price target on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research note on Monday, August 12th. Finally, Evercore ISI lowered their price target on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Eleven research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $72.10.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.